{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:33:18Z","timestamp":1789651998800,"version":"4.0.0"},"reference-count":94,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1136\/jnnp-2012-304022","type":"journal-article","created":{"date-parts":[[2013,2,2]],"date-time":"2013-02-02T02:29:58Z","timestamp":1359772198000},"page":"1126-1137","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":59,"title":["HIV, dementia and antiretroviral drugs: 30\u2005years of an epidemic"],"prefix":"10.1136","volume":"84","author":[{"given":"Hadi","family":"Manji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H R","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Winston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,2,1]]},"reference":[{"key":"key-10.1136\/jnnp-2012-304022-1","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-1 associated neurocognitive disorders","volume":"69","author":"Antori","year":"2007","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-304022-2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.22053","article-title":"Human Immunodeficiency Virus\u2014Associated Neurocognitive Disorders Mind the Gap","volume":"67","author":"McArthur","year":"2010","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2012-304022-3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(12)70098-4","article-title":"HIV-associated opportunistic infections of the CNS","volume":"11","author":"Tan","year":"2012","journal-title":"Lancet Neurology"},{"key":"key-10.1136\/jnnp-2012-304022-4","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198512123132401","article-title":"Isolation of HTLV-111 from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome","volume":"313","author":"Ho","year":"1985","journal-title":"N Eng J Med"},{"key":"key-10.1136\/jnnp-2012-304022-5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.7326\/0003-4819-106-5-692","article-title":"Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid","volume":"106","author":"Hollander","year":"1987","journal-title":"Ann Int Med"},{"key":"key-10.1136\/jnnp-2012-304022-6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1086\/343768","article-title":"The central nervous system as a resevoir for simian immunodeficiency virus (SIV): steady state levels of SIV DNA in brain from acute through asymptomatic infection","volume":"186","author":"Clements","year":"2002","journal-title":"J Infect Dis"},{"key":"key-10.1136\/jnnp-2012-304022-7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002030-198804000-00002","article-title":"Neuropsychological characterisation of the AIDS dementia complex: a preliminary report","volume":"2","author":"Tross","year":"1988","journal-title":"AIDS"},{"key":"key-10.1136\/jnnp-2012-304022-8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/jnnp.55.2.143","article-title":"Neurological and neuropsychological performance in HIV seropositive men without symptoms","volume":"55","author":"McAllister","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2012-304022-9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ana.410260504","article-title":"Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1 infected individuals: results from the multicentre AIDS cohort study (MACS)","volume":"26","author":"McArthur","year":"1989","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2012-304022-10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/infdis\/168.4.818","article-title":"Human immmunodeficency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects","volume":"168","author":"Bell","year":"1993","journal-title":"J Infect Disease"},{"key":"key-10.1136\/jnnp-2012-304022-11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1750-3639.1996.tb00775.x","article-title":"Neuropathology of early HIV-1 infection","volume":"6","author":"Gray","year":"1996","journal-title":"Brain Pathology"},{"key":"key-10.1136\/jnnp-2012-304022-12","first-page":"1058","article-title":"B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas. Brain","volume":"126","author":"Anthony","year":"2003"},{"key":"key-10.1136\/jnnp-2012-304022-13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/13550289809114526","article-title":"SIV infection of macaques\u2014modelling the progression to AIDS dementia","volume":"4","author":"Zinc","year":"1998","journal-title":"J Neurovirol"},{"key":"key-10.1136\/jnnp-2012-304022-14","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.43.11.2245","article-title":"Dementia in AIDS patients: incidence and risk factors","volume":"43","author":"McArthur","year":"1993","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-304022-15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/13550280600915339","article-title":"Lowest ever CD4 lymphocyte count (CD4 nadir) as apredictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection: The Hawaii Aging HIV Cohort","volume":"12","author":"Valcour","year":"2006","journal-title":"J Neurovirol"},{"key":"key-10.1136\/jnnp-2012-304022-16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/01.WNL.0000134665.58343.8D","article-title":"Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 cohort","volume":"63","author":"Valcour","year":"2004","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-304022-17","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.43.11.2245","article-title":"Dementia in AIDS patients: incidence and risk factors. Multicentre AIDS Cohort Study","volume":"43","author":"McArthur","year":"1993","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-304022-18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1749-6632.2009.05277.x","article-title":"Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction","volume":"1187","author":"Nath","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.1136\/jnnp-2012-304022-19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11481-009-9154-6","article-title":"Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders","volume":"4","author":"Jayadev","year":"2009","journal-title":"J Neuroimmune Pharmacol"},{"key":"key-10.1136\/jnnp-2012-304022-20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1355617704101021","article-title":"Metamphetamine dependance increases risk of neuropsychological impairment in HIV infected persons","volume":"10","author":"Rippeth","year":"2004","journal-title":"J Int Neuropsychol Soc"},{"key":"key-10.1136\/jnnp-2012-304022-21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jneuroim.2004.08.029","article-title":"Age, apolipoprotein E4 and the risk of HIV dementia: the Hawaii aging with HIV-1 cohort","volume":"157","author":"Valcour","year":"2004","journal-title":"J Neuroimmunology"},{"key":"key-10.1136\/jnnp-2012-304022-22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ana.1284","article-title":"Increased frequency of the tumour necrosios factor alpha 308 A allele in adults with human immunodeficiency virus dementia","volume":"50","author":"Quasney","year":"2001","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2012-304022-23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2004.08.027","article-title":"CCR2 polymorphisms affect neuropsychological impairment in HIV-1 infected adults","volume":"157","author":"Singh","year":"2004","journal-title":"J Neuroimmunology"},{"key":"key-10.1136\/jnnp-2012-304022-24","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1097\/01.aids.0000238404.16121.47","article-title":"Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection","volume":"20","author":"Parsons","year":"2006","journal-title":"AIDS"},{"key":"key-10.1136\/jnnp-2012-304022-25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1300\/J069v27n02_02","article-title":"Neurocognition in individuals co-infected with HIV and hepatitis C","volume":"27","author":"Hinkin","year":"2008","journal-title":"J Addict Dis"},{"issue":"suppl 3","key":"key-10.1136\/jnnp-2012-304022-26","doi-asserted-by":"crossref","first-page":"s64","DOI":"10.1097\/01.aids.0000192072.80572.43","article-title":"The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV\u2014infected subjects","volume":"19","author":"Clifford","year":"2005","journal-title":"AIDS"},{"key":"key-10.1136\/jnnp-2012-304022-27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/605284","article-title":"HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda","volume":"49","author":"Sacktor","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/jnnp-2012-304022-28","doi-asserted-by":"crossref","first-page":"10010","DOI":"10.1523\/JNEUROSCI.2955-08.2008","article-title":"HIV-1 clade-specific differences in the induction of neuropathogenisis","volume":"28","author":"Rao","year":"2008","journal-title":"J Neurosci"},{"key":"key-10.1136\/jnnp-2012-304022-29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1017\/S1355617706060516","article-title":"Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus","volume":"12","author":"Yepthomi","year":"2006","journal-title":"J Int Neuropsychol Soc"},{"key":"key-10.1136\/jnnp-2012-304022-30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nic.2007.12.013","article-title":"Neuroimaging in the brain in HIV-1 infected patients","volume":"18","author":"Thurnher","year":"2008","journal-title":"Neuroimaging Clin N Am"},{"key":"key-10.1136\/jnnp-2012-304022-31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neuroimage.2006.08.030","article-title":"3D pattern of brain atrophy in HIV\/AIDS visualised using tensor based morphometry","volume":"34","author":"Chiang","year":"2007","journal-title":"Neuroimage"},{"key":"key-10.1136\/jnnp-2012-304022-32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00688301","article-title":"Multinucleated giant cells in the brain: a hallmark of the acquired immune deficiency syndrome (AIDS)","volume":"69","author":"Budka","year":"1986","journal-title":"Acta Neuropathol (Berl)"},{"key":"key-10.1136\/jnnp-2012-304022-33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/09540260701862037","article-title":"The neuropathology of AIDS","volume":"20","author":"Anthony","year":"2008","journal-title":"Int Rev Psychiatry"},{"key":"key-10.1136\/jnnp-2012-304022-34","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ana.410380510","article-title":"Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia","volume":"38","author":"Glass","year":"1995","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2012-304022-35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1750-3639.1991.tb00656.x","article-title":"The neuropathology of human immunodeficiency virus virus infection","volume":"1","author":"Budka","year":"1991","journal-title":"Brain Pathol"},{"key":"key-10.1136\/jnnp-2012-304022-36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jnnp.56.5.481","article-title":"Neuronal number and volume alterations in the neocortex of HIV infected individuals","volume":"56","author":"Everall","year":"1993","journal-title":"J Neurol Neursurg Psychiatry"},{"key":"key-10.1136\/jnnp-2012-304022-37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0301-0082(97)00053-1","article-title":"Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms","volume":"54","author":"Nath","year":"1998","journal-title":"Prog Neurobiol"},{"key":"key-10.1136\/jnnp-2012-304022-38","doi-asserted-by":"crossref","first-page":"17098","DOI":"10.1074\/jbc.274.24.17098","article-title":"transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon","volume":"274","author":"Nath","year":"1999","journal-title":"J Biol Chem"},{"key":"key-10.1136\/jnnp-2012-304022-39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF03402144","article-title":"Rate and severity of HIV-associated dementia: correlations with gp41 and iNOS","volume":"5","author":"Adamson","year":"1999","journal-title":"Mol Med"},{"key":"key-10.1136\/jnnp-2012-304022-40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(96)00160-9","article-title":"Cellular localization of tumour necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transciptase polymerase chain reaction in situ hybridization and immunohistochemistry","volume":"74","author":"Wesselingh","year":"1997","journal-title":"J Neuroimmunol"},{"key":"key-10.1136\/jnnp-2012-304022-41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/brain\/124.5.1033","article-title":"Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volumne loss in HIV infection","volume":"124","author":"Heyes","year":"2001","journal-title":"Brain"},{"key":"key-10.1136\/jnnp-2012-304022-42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/135502801300069692","article-title":"Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef, and Tat","volume":"7","author":"Smith","year":"2001","journal-title":"J Neurovirol"},{"key":"key-10.1136\/jnnp-2012-304022-43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.21697","article-title":"Extensive astrocyte infection is prominent in human immunodeficiency virus associated dementia","volume":"66","author":"Churchill","year":"2009","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2012-304022-44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/1570162033485122","article-title":"Astrocyte infection by HIV-1: mechanisms of restricted virus replication and role in the pathogenesis of HIV-1 associated dementia","volume":"1","author":"Gorry","year":"2003","journal-title":"Curr HIV Res"},{"key":"key-10.1136\/jnnp-2012-304022-45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410330403","article-title":"Zidovudine treatment of the AIDS dementia complex: results of a placebo controlled trial. AIDS Clinical Trials Group","volume":"33","author":"Sidtis","year":"1993","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2012-304022-46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2004.08.042","article-title":"HIV dementia: an evolving disease","volume":"157","author":"McArthur","year":"2004","journal-title":"J Neuroimmunology"},{"key":"key-10.1136\/jnnp-2012-304022-47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.56.2.257","article-title":"HIV-associated neurological disease incidence changes: multicentre AIDS Cohort Study, 1990\u20131998","volume":"56","author":"Sacktor","year":"2001","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-304022-48","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. CHARTER study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-304022-49","first-page":"17","article-title":"Effects of advances in therapy on the neuropathology of HIV infection","volume":"5","author":"Anthony","year":"2005","journal-title":"ACNR"},{"key":"key-10.1136\/jnnp-2012-304022-50","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/13550280600713932","article-title":"Relationnship of antiretroviral treatment to post mortem brain tissue viral load in human inmmunodeficinecy virus-infected patients","volume":"12","author":"Langford","year":"2006","journal-title":"J Neurovirology"},{"key":"key-10.1136\/jnnp-2012-304022-51","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnen\/64.6.529","article-title":"Influence of HAART on HIV_related CNS disease and neuroinflammation","volume":"64","author":"Anthony","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"key-10.1136\/jnnp-2012-304022-52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.aids.0000161770.06158.5c","article-title":"Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients","volume":"19","author":"Green","year":"2005","journal-title":"AIDS"},{"key":"key-10.1136\/jnnp-2012-304022-53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/13550281003682513","article-title":"Does highly active antiretroviral therapy impriove neurocognitive function? A systemic review","volume":"16","author":"Joska","year":"2010","journal-title":"J Neurovirol"},{"key":"key-10.1136\/jnnp-2012-304022-54","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.0b013e3181ab2b3b","article-title":"Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy","volume":"73","author":"Cysique","year":"2009","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-304022-55","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/13550280490521078","article-title":"Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected\/acquired immunodeficiency syndrome (HIV\/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts","volume":"10","author":"Cysique","year":"2004","journal-title":"J Neurovirology"},{"key":"key-10.1136\/jnnp-2012-304022-56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature and predictors","volume":"17","author":"Heaton","year":"2011","journal-title":"J Neurovirol"},{"key":"key-10.1136\/jnnp-2012-304022-57","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/13550280290049615","article-title":"HIV-associated cognitive impairment before and after the advent of combination therapy","volume":"8","author":"Sacktor","year":"2002","journal-title":"J Neurovirol"},{"key":"key-10.1136\/jnnp-2012-304022-58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/QAI.0b013e318042e1ee","article-title":"Persistence of neuropsychologic deficits despite long term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors","volume":"45","author":"Tossi","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.1136\/jnnp-2012-304022-59","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders (HAND) persist in the era of potent antiretroviral therapy: the CHARTER study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-304022-60","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/QAD.0b013e32828e4e27","article-title":"The prevalence and incidence of neurocognitive impairment in the HAART era","volume":"21","author":"Robertson","year":"2007","journal-title":"AIDS"},{"key":"key-10.1136\/jnnp-2012-304022-61","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/QAD.0b013e3283354a7b","article-title":"Cognitive dysfunction in HIV patients despite long-standing suppression of viraemia","volume":"24","author":"Simioni","year":"2010","journal-title":"AIDS"},{"key":"key-10.1136\/jnnp-2012-304022-62","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/13803395.2010.547662","article-title":"Relationship of ethnicity, age, education and reading level to speed and executive function among HIV+ and HIV\u2212 women: the Women's Interagency HIV Study (WIHS) Neurocognitive substudy","volume":"33","author":"Manly","year":"2011","journal-title":"J Clin Exp Neuropsychol"},{"key":"key-10.1136\/jnnp-2012-304022-63","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s10461-010-9684-1","article-title":"Neurocognitive impairment and HIV risk factors: a reciprocal relationship","volume":"14","author":"Anand","year":"2010","journal-title":"AIDS Behav"},{"key":"key-10.1136\/jnnp-2012-304022-64","first-page":"317","article-title":"Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection","volume":"57","author":"Lyons","year":"2011","journal-title":"Acquir Immune Defic Syndr"},{"key":"key-10.1136\/jnnp-2012-304022-65","doi-asserted-by":"crossref","first-page":"s294","DOI":"10.1086\/533419","article-title":"Antiretroviral therapy and central nervous system HIV type 1 infection","volume":"197","author":"Price","year":"2008","journal-title":"J Infect Dis"},{"key":"key-10.1136\/jnnp-2012-304022-66","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410420504","article-title":"Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain","volume":"42","author":"McArthur","year":"1997","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2012-304022-67","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archneur.59.6.923","article-title":"Progression to neuropsychiatric impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA","volume":"59","author":"Ellis","year":"2002","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2012-304022-68","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1097\/QAD.0b013e32833e9245","article-title":"HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitis","author":"Soulie","year":"2010","journal-title":"AIDS"},{"key":"key-10.1136\/jnnp-2012-304022-69","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00002030-199906180-00008","article-title":"Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection","volume":"13","author":"Staprans","year":"1999","journal-title":"AIDS"},{"key":"key-10.1136\/jnnp-2012-304022-70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/rmv.454","article-title":"Factors affecting delivery of antiviral drugs to the brain","volume":"15","author":"Strazielle","year":"2005","journal-title":"Rev Med Virol"},{"key":"key-10.1136\/jnnp-2012-304022-71","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1128\/AAC.39.12.2779","article-title":"Pharmacokinetics of lamivudine and BCH-189 in plasma and nonhuman primates","volume":"39","author":"Blaney","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.1136\/jnnp-2012-304022-72","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2217\/fvl.11.71","article-title":"Effects of different antiretroviral agents on cerebral function in HIV-infected individuals","volume":"6","author":"Winston","year":"2011","journal-title":"Future Virol"},{"key":"key-10.1136\/jnnp-2012-304022-73","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","article-title":"Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system","volume":"65","author":"Letendre","year":"2008","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2012-304022-74","article-title":"Correlates of CSF viral loads in 1221 volunteers in the CHARTER cohort. Presented at: 17th Conference on Retroviruses and Opportunistic Infections","author":"Letendre","year":"2010"},{"key":"key-10.1136\/jnnp-2012-304022-75","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/QAD.0b013e32834171f8","article-title":"Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort","volume":"25","author":"Smurzynski","year":"2011","journal-title":"AIDS"},{"key":"key-10.1136\/jnnp-2012-304022-76","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/QAD.0b013e32832c4152","article-title":"Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance","volume":"23","author":"Marra","year":"2009","journal-title":"AIDS"},{"key":"key-10.1136\/jnnp-2012-304022-77","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1212\/WNL.0b013e3181d9ed09","article-title":"Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort","volume":"74","author":"Robertson","year":"2010","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-304022-78","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","article-title":"Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients","volume":"76","author":"Ciccarelli","year":"2011","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-304022-79","article-title":"CNS toxicity of antiretroviral drugs. 17th Conference on Retroviruses and Opportunistic Infections","author":"Liner","year":"2010"},{"key":"key-10.1136\/jnnp-2012-304022-80","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/13550280591002342","article-title":"Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors","volume":"11","author":"Schweinsburg","year":"2005","journal-title":"J Neurovirol"},{"key":"key-10.1136\/jnnp-2012-304022-81","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/ng.863","article-title":"Mitochondrial aging is accelerated by anti-retroviral therapy through the cloncal expansion of mtDNA mutations","volume":"43","author":"Payne","year":"2011","journal-title":"Nature Genetics"},{"key":"key-10.1136\/jnnp-2012-304022-82","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF01646922","article-title":"Cytological and immunoglobulin findings in cerebrospinal fluid of symptomatic and asymptomatic human immunodeficiency virus (HIV) seropositive patients","volume":"16","author":"Hagberg","year":"1988","journal-title":"Infection"},{"key":"key-10.1136\/jnnp-2012-304022-83","first-page":"59","article-title":"A guide to interpretation of neuroimmunological biomarkers in the combined antiretroviral therapy era of HIV central nervous system disease","volume":"2","author":"Morris","year":"2010","journal-title":"Neurobehavioural HIV Med"},{"key":"key-10.1136\/jnnp-2012-304022-84","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1212\/WNL.42.9.1707","article-title":"The diagnostic utility of elevation in cerebrospinal fluid bets 2 microglobulin in HIV-1 dementia","volume":"42","author":"McArthur","year":"1992","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-304022-85","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1086\/523648","article-title":"Immune activation of the central nervous system is still present after >4\u2005years of effective highly active antiretroviral therapy","volume":"196","author":"Eden","year":"2007","journal-title":"J Infectious Dis"},{"key":"key-10.1136\/jnnp-2012-304022-86","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/QAD.0b013e3283427da7","article-title":"Persistence of HIV-associated cognitive impairment, inflammation and neuronal injury in era of highly active antiretroviral treatment","volume":"25","author":"Harezlak","year":"2011","journal-title":"AIDS"},{"key":"key-10.1136\/jnnp-2012-304022-87","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/QAI.0b013e3181e66216","article-title":"Inflammation and mortality in HIV-infected adults: analysis of the FRAM Study cohort","volume":"55","author":"Tien","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.1136\/jnnp-2012-304022-88","doi-asserted-by":"crossref","first-page":"e2516","DOI":"10.1371\/journal.pone.0002516","article-title":"Microbial translocation is associated with invreased monocyte activation and dementia in AIDS patients","volume":"3","author":"Ancuta","year":"2008","journal-title":"PLoS ONE"},{"key":"key-10.1136\/jnnp-2012-304022-89","article-title":"Escape is uncommon in HIV-1 infected patients on stable ART. 17th Conference on Retroviruses and Opportunistic infections","author":"Eden","year":"2010"},{"key":"key-10.1136\/jnnp-2012-304022-90","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jinf.2009.12.009","article-title":"Spectrum of neurological disease in patients with discordant HIV-1RNA levels in plasma and cerebrospinal fluid","volume":"60","author":"Scourfield","year":"2010","journal-title":"J of Infection"},{"key":"key-10.1136\/jnnp-2012-304022-91","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1086\/378300","article-title":"Acute meningoencephalitis in chronic human immunodeficiency virus (HIV) infection: putative central nervous system escape of HIV replication","volume":"37","author":"Wendel","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/jnnp-2012-304022-92","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/650538","article-title":"Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy","volume":"50","author":"Canestri","year":"2010","journal-title":"Clin Infec Diseases"},{"key":"key-10.1136\/jnnp-2012-304022-93","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1258\/ijsa.2009.008521","article-title":"A brief review of potential mechanisms of immune reconstitution syndrome in HIV following antiretroviral therapy","volume":"20","author":"Mori","year":"2009","journal-title":"Int J STD and AIDS"},{"key":"key-10.1136\/jnnp-2012-304022-94","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ncpneuro0303","article-title":"Therapy insight: CNS manifestations of HIV-associated immune reconstitution syndrome","volume":"2","author":"Riedal","year":"2006","journal-title":"Nat Clin Pract"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2012-304022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T11:29:08Z","timestamp":1714908548000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2012-304022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,1]]},"references-count":94,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,9,2]]},"published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1136\/jnnp-2012-304022"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2012-304022","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,1]]}}}